Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ondansetron to reduce ketamine-related vomiting in children
IRCT201301189162N7Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Mar 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of ondansetron in nausea ((none)) and Vomiting, sponsored by Tehran University of Medical Sciences. Primary endpoint: Incidence of ketamine-related vomiting. Started Mar 2013; status: completed.
02
Drugs
ondansetron
03
Conditions
nausea ((none))Vomiting
Beyond the preview
Go deeper on IRCT201301189162N7.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201301189162N7.